Braden McCurrach is a special counsel in Cadwalader's Corporate Group. His practice involves counseling clients in a broad range of complex transactional matters, including public and private mergers, acquisitions, divestitures, proxy contests, tender offers, spinoffs and joint ventures. Braden's practice also includes the representation of investment banks in their capacity as financial advisors on M&A and other transactions. In addition to his transactional experience, Braden advises clients in a wide array of governance, securities and other commercial matters, including directors' duties and responsibilities, board composition, disclosure issues and compliance.
Recently named a “Key Individual” for his work in M&A: Large Deals by The Legal 500 US, Braden was also recognized by Super Lawyers as a New York Metro mergers and acquisitions “Rising Star.” He received his A.B. from Duke University and his J.D. from the University of Michigan Law School. Braden McCurrach is admitted to practice law in the State of New York as well as in the U.S. District Court for the Southern District of New York and the U.S. District Court for the Eastern District of New York.
•The Pasha Group in its acquisition of the Hawaii trade-lane business of Horizon Lines
•Medifast in its agreement with Engaged Capital
•Cigna Corporation in connection with the public offering of $900 million of 3.250% Senior Notes due 2025
•Jos. A. Bank's financial advisor in connection with its agreement to acquire Eddie Bauer and its subsequent sale to Men's Wearhouse
•Air Products and Chemicals in its agreement with Pershing Square Capital Management following the 9.8% investment position taken by Bill Ackman
•Dell's financial advisor in connection with its $24.9 billion acquisition by Michael Dell and Silver Lake Partners
•elan in the $3.25 billion sale of its interest in TYSABRI to Biogen Idec
•The United States Department of the Treasury in the management of its $250 billion TARP Capital Purchase Program
•Triarco Industries in its sale to Innophos
•AngioDynamics in its acquisitions of Navilyst Medical, Microsulis Medical, Vortex Medical and Clinical Devices
•The Special Committee of the Board of Directors of Landry's Restaurants in the acquisition of Landry's by Tilman J. Fertitta
•Celanese in the sale of its polyvinyl alcohol business to Sekisui Chemical Co.
•Trian Fund Management in its $166 million tender offer for shares of Wendy's/Arby's Group
•Pfizer in its $68 billion acquisition of Wyeth
•Bear Stearns in its acquisition by JPMorgan Chase & Co.
•Charming Shoppes in its proxy contest with Crescendo Investments
•CosI, Inc. in its rights offering to common stockholders
•Trian Fund Management in its proxy contest with H.J. Heinz Company
•Wilshire Enterprises in its proxy contest with Bulldog Investors funds and subsequent self-tender offer to purchase half of Wilshire's outstanding shares
•Gyrodyne Company of America in its proxy contest with Bulldog Investors funds
•Xstrata in its sale of its Noranda aluminum division to Apollo Management
• Cadwalader Promotes Eight Attorneys to Special Counsel
Nov 20, 2015
• New Deals - Lawyers on Major Transactions
Jan 29, 2009
• Cadwalader Attorneys Recognized in 2015 New York Super Lawyers and Rising Stars Lists
Sep 17, 2015
Clients & Friends Memos
• M&A Update: Highlights from 2015 and Implications for 2016
Jan 19, 2016